GTR 62542623
Tenders Are Invited For Lot 1 – Medicinal Products Affecting The Cardiovascular And Blood Systems And Hematopoiesis: L-Lysine Escinate Solution D/In. 1 Mg/Ml In 5 Ml No. 10 (5X2) In Amp. (Lysine); Vikasol Solution D/In. 10 Mg/Ml Per 1 Ml No. 10 (5X2) In Amp. (Menadione); Tahiben Solution D/In. 5 Mg/Ml (50 Mg) Per 10 Ml No. 5 In Amp. (Urapidil); Ethamsylate Solution D/In. 125 Mg/Ml Of 2 Ml No. 10 In Amp. (Etamsylate); Corvitin Lyophilisate For The District D/In. 0.5 G Of No. 5 In A Flask. (Quercetin); Calcium Chloride Solution D/In. 100 Mg/Ml In 5 Ml No. 10 In Amp. (Calcium Chloride); Contriven Solution D/In. 10,000 Kio/Ml For 5 Ml No. 5 In Amp. (Aprotinin). Lot 2 – Medicines Affecting The Cardiovascular And Blood Systems And Hematopoiesis: Norepinephrine Tartrate Agetan 2 Mg/Ml (Without Sulfites) Concentrate For R-Nu D/Inf. 4 Ml Of No. 10 In Amp. (Norepinephrine); Sterofundin Iso Solution D/Inf. 500 Ml Each. (Electrolytes); Torsid Solution D/In. 5 Mg/Ml For 4 Ml No. 5 In Amp. (Torasemi
ICB — International Competitive Bid
Closed
Eastern Europe
Tender Information
GTR Reference
62542623
Tendering Authority
Subscribe to view
Tender No
UA-2023-03-24-010504-a
Financer Name
Self-Funded
Work Title
Tenders Are Invited For Lot 1 – Medicinal Products Affecting The Cardiovascular And Blood Systems And Hematopoiesis: L-Lysine Escinate Solution D/In. 1 Mg/Ml In 5 Ml No. 10 (5X2) In Amp. (Lysine); Vikasol Solution D/In. 10 Mg/Ml Per 1 Ml No. 10 (5X2) In Amp. (Menadione); Tahiben Solution D/In. 5 Mg/Ml (50 Mg) Per 10 Ml No. 5 In Amp. (Urapidil); Ethamsylate Solution D/In. 125 Mg/Ml Of 2 Ml No. 10 In Amp. (Etamsylate); Corvitin Lyophilisate For The District D/In. 0.5 G Of No. 5 In A Flask. (Quercetin); Calcium Chloride Solution D/In. 100 Mg/Ml In 5 Ml No. 10 In Amp. (Calcium Chloride); Contriven Solution D/In. 10,000 Kio/Ml For 5 Ml No. 5 In Amp. (Aprotinin). Lot 2 – Medicines Affecting The Cardiovascular And Blood Systems And Hematopoiesis: Norepinephrine Tartrate Agetan 2 Mg/Ml (Without Sulfites) Concentrate For R-Nu D/Inf. 4 Ml Of No. 10 In Amp. (Norepinephrine); Sterofundin Iso Solution D/Inf. 500 Ml Each. (Electrolytes); Torsid Solution D/In. 5 Mg/Ml For 4 Ml No. 5 In Amp. (Torasemi
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
Eastern Europe
Political Region
Commonwealth of Independent States CIS
Last Date of Bid Submission
02-04-2023
Closed
Work Detail
L-Lysine Escinate Solution D/In. 1 Mg/Ml Per 5 Ml No. 10 (5X2) In Amp. (Lysine), Vikasol Solution D/In. 10 Mg/Ml Per 1 Ml No. 10 (5X2) In Amp. (Menadione), Tahiben Solution D/In. 5 Mg/Ml (50 Mg) Per 10 Ml No. 5 Amp. (Urapidil), Ethamsylate Solution D/In. 125 Mg/Ml 2 Ml No. 10 V Amp. (Etamsylate), Corvitin Lyophilizate For P-Nu D/In. Each 0.5 G No. 5 In Flak. (Quercetin), Calcium Chloride Solution D/In. 100 Mg/Ml Per 5 Ml No. 10 V Amp. (Calciumchloride), Kontriven Solution D/In. 10000 Kio/Ml Per 5 Ml No. 5 V Amp. (Aprotinin), Norepinephrine Tartrate Agetan 2 Mg/Ml (Without Sulfites) Concentrate For P-Nu D/Inf. Each 4 Ml No. 10 V Amp. (Norepinephrine), Sterofundin Iso Solution D/Inf. 500 Ml Each. (Electrolytes), Torsid Solution D/In. 5 Mg/Ml Per 4 Ml No. 5 V Amp. (Torasemide), Isosol Solution D/Inf. Each 500 Ml In Cont. (Electrolytes), Thiotriazoline Solution D/In. 2.5% Per 2 Ml No. 10 V Amp. (Tiazoticacid), Nicotinic Acid Solution D/In. 10 Mg/Ml Per 1 Ml No. 10 (5X2) In Amp. (Nicotinic Acid), Eglonil Solution D/In. 100 Mg/2 Ml Per 2 Ml No. 6 V Amp. (Sulpiride), Nefam Solution D/In. 10 Mg/Ml In 2 Ml No. 5 Amp. (Nefopam), Corvalol Drops Or. 50 Ml Each In Flak. From Prob.-Krap. (Barbiturates In Combination With Other Drugs), Barboval Drops Or. 25 Ml Each In Flak. From Prob.-Krap. (Barbiturates In Combination With Other Drugs), Novocaine Solution D/In. 2% By 2 Ml No. 10 V Amp. (Procaine), Volutenz Solution D/Inf. Bottles Of 500 Ml Each. (Gelatin Agents), Biblock Solution D/Inf. 10 Mg/Ml Of 50 Ml In Cont. Polym. (Esmolol), Quanadex Concentrate For P-Well D/Inf. 100 Μg/Ml Per 2 Ml No. 5 V Amp. (Dexmedetomidine), Xavron Solution D/In. 1.5 Mg/Ml Per 20 Ml No. 10 (5X2) In Amp. (Edaravone), Xylate Solution D/Inf. 200 Ml Each In Bottles. (Electrolytes In Combination With Other Drugs), Neurocytin Solution D/Inf. Bottles Of 200 Ml Each. (Electrolytes In Combination With Other Drugs), Novocaine Solution D/In. 0.5% 200 Ml No. 1 In Bottles. (Procaine), Reosorbilact Solution D/Inf. Bottles Of 200 Ml Each. (Electrolytes In Combination With Other Drugs), Sorbilakt Solution D/Inf. Bottles Of 200 Ml Each. (Electrolytes In Combination With Other Drugs), Sufer Solution D/In. I/V 20 Mg/Ml Per 5 Ml No. 5 V Amp. (Saccharated Iron Oxide), Trisol Solution D/Inf. Bottles Of 200 Ml Each. (Electrolytes), Dexketoprofen Solution D/In. 25 Mg/Ml Per 2 Ml No. 5 (5X1) In Amp. (Dexketoprofen), Asparkam Solution D/In. Each 10 Ml No. 10 V Amp. (Magnesium (Different Salts In Combination), Ascorbic Acid Solution D/In. 50 Mg/Ml 2 Ml No. 10 V Amp. (Ascorbic Acid (Vit C), Thiamine Chloride (Vitamin B1) Solution D/In. 50 Mg/ Ml Per 1 Ml No. 10 (5X2) In Amp. (Thiamine (Vit B1), Pyridoxine (Vitamin B6) Solution D/In. 50 Mg/Ml Per 1 Ml No. 10 (5X2) In Amp. (Pyridoxine (Vit B6) ), Glutargin Solution D/Inf. 20% 5 Ml No. 10 V Amp. 20 Mg/Ml Per 2 Ml No. 10 V Amp. (Papaverine), Platyphyllin Solution D/In. 2 Mg/Ml Per 1 Ml No. 10 (5X2) V Amp. (Platyphylline), Renalgan Solution D/In. 2 Ml Each No. 10 V Amp. . ), Cordiamine Solution D/In. 250 Mg/Ml Per 2 Ml No. 10 V Amp. (Nikethamide), Soup Plant Solution D/In. 20 Mg/Ml Per 1 Ml No. 5 V Amp. (Chloropyramine), Oktra Solution D/In. 0.1 Mg/Ml Per 1 Ml No. 5 V Amp. (Octreotide), Levomycetin Drops Och. 0.25% 10 Ml In Flak. (Chloramphenicol)
Key Value
Tender Value
706,826 - UAH
Tender Documents
Global Tender Document
3bf65210-64b2-4684-909a-315592ecde89.html
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.